Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY5R | Q15761 | 1/20 | 0.32 |
| ▸ | CCNT1 | O60563 | 3/20 | 0.32 |
| ▸ | CDK9 | P50750 | 3/20 | 0.32 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.31 |
| ▸ | EGFR | P00533 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12793513 | 0.89 | NPY5R (0.30) | NPY5RCCNT1CDK9 | |
| SCHEMBL3298700 | 0.88 | CCNT1 (0.37) | NPY5RCCNT1CDK9HDAC1EGFR | |
| SCHEMBL14536807 | 0.86 | NPY5R (0.36) | NPY5RCCNT1CDK9HDAC1EGFR | |
| SCHEMBL13242789 | 0.81 | CCNT1 (0.33) | NPY5RCCNT1CDK9HDAC1 | |
| SCHEMBL13780011 | 0.81 | HDAC1 (0.39) | NPY5RCCNT1CDK9HDAC1 | |
| SCHEMBL9970481 | 0.80 | NPY5R (0.41) | NPY5RCCNT1CDK9HDAC1EGFR | |
| SCHEMBL14536648 | 0.78 | HDAC1 (0.40) | NPY5RCCNT1CDK9HDAC1 | |
| SCHEMBL13780008 | 0.76 | CCNT1 (0.40) | NPY5RCCNT1CDK9HDAC1 | |
| SCHEMBL13520156 | 0.76 | NPY5R (0.32) | NPY5RCCNT1CDK9HDAC1EGFR | |
| SCHEMBL10018351 | 0.76 | NPY5R (0.32) | NPY5RCCNT1CDK9HDAC1EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100066241-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-03-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100066241-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | IL33, ORMDL3, CCND3 | NPY5R 637/4885CCNT1 392/4885CDK9 3040/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.